Literature DB >> 32553750

The tumour microenvironment of pituitary neuroendocrine tumours.

Pedro Marques1, Ashley B Grossman2, Márta Korbonits3.   

Abstract

The tumour microenvironment (TME) includes a variety of non-neoplastic cells and non-cellular elements such as cytokines, growth factors and enzymes surrounding tumour cells. The TME emerged as a key modulator of tumour initiation, progression and invasion, with extensive data available in many cancers, but little is known in pituitary tumours. However, the understanding of the TME of pituitary tumours has advanced thanks to active research in this field over the last decade. Different immune and stromal cell subpopulations, and several cytokines, growth factors and matrix remodelling enzymes, have been characterised in pituitary tumours. Studying the TME in pituitary tumours may lead to a better understanding of tumourigenic mechanisms, identification of biomarkers useful to predict aggressive disease, and development of novel therapies. This review summarises the current knowledge on the different TME cellular/non-cellular elements in pituitary tumours and provides an overview of their role in tumourigenesis, biological behaviour and clinical outcomes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemokine; Cytokine; Epithelial-to-mesenchymal transition; Extracellular matrix; Growth factor; Immune cell; Pituitary neuroendocrine tumour; Stromal cell; Tumour microenvironment

Year:  2020        PMID: 32553750     DOI: 10.1016/j.yfrne.2020.100852

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  8 in total

Review 1.  Aggressive pituitary tumours and pituitary carcinomas.

Authors:  Gérald Raverot; Mirela Diana Ilie; Hélène Lasolle; Vincent Amodru; Jacqueline Trouillas; Frédéric Castinetti; Thierry Brue
Journal:  Nat Rev Endocrinol       Date:  2021-09-07       Impact factor: 43.330

Review 2.  The application of tumor cell-derived vesicles in oncology therapy.

Authors:  Ximei Xu; Yin Xiang; Yang Yang; Kai Liu; Zhiwei Cui; Xiaodong Tong; Junliang Chen; Fang Hou; Zhiqiang Luo
Journal:  Clin Transl Oncol       Date:  2022-10-07       Impact factor: 3.340

3.  Prognostic and Immunological Value of GNB4 in Gastric Cancer by Analyzing TCGA Database.

Authors:  Binghui Liu; Lingbin Chen; He Huang; Huifeng Huang; Hui Jin; Chenglin Fu
Journal:  Dis Markers       Date:  2022-06-16       Impact factor: 3.464

4.  Sprouting Angiogenesis in Human Pituitary Adenomas.

Authors:  Jie Zhou; Yaomin Hu; Wende Zhu; Chuansheng Nie; Wenxiu Zhao; Alexander T Faje; Kay E Labelle; Brooke Swearingen; Hang Lee; E Tessa Hedley-Whyte; Xun Zhang; Pamela S Jones; Karen K Miller; Anne Klibanski; Yunli Zhou; Roy J Soberman
Journal:  Front Oncol       Date:  2022-05-05       Impact factor: 5.738

Review 5.  The Role of Exosomes and Their Applications in Cancer.

Authors:  Yuju Zhou; Ying Zhang; Huan Gong; Siqi Luo; Yan Cui
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

6.  Intratumoural spatial distribution of S100B + folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours.

Authors:  Mirela Diana Ilie; Alexandre Vasiljevic; Marie Chanal; Nicolas Gadot; Laura Chinezu; Emmanuel Jouanneau; Ana Hennino; Gérald Raverot; Philippe Bertolino
Journal:  Acta Neuropathol Commun       Date:  2022-02-09       Impact factor: 7.801

Review 7.  Serum Inflammation-based Scores in Endocrine Tumors.

Authors:  Pedro Marques; Friso de Vries; Olaf M Dekkers; Márta Korbonits; Nienke R Biermasz; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

Review 8.  Genetics of Acromegaly and Gigantism.

Authors:  Anna Bogusławska; Márta Korbonits
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.